Login / Signup

Subnanomolar Affinity and Selective Antagonism at α7 Nicotinic Receptor by Combined Modifications of 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624).

Francesco BavoMarco PallaviciniSusanna PucciRebecca AppianiAlessandro GiraudoHyoungil OhDana L KneisleyBrek EatonLinda LuceroCecilia GottiFrancesco ClementiPaul WhiteakerCristiano Bolchi
Published in: Journal of medicinal chemistry (2022)
Modifications of the cationic head and the ethylene linker of 2-(triethylammonium)ethyl ether of 4-stilbenol (MG624) have been proved to produce selective α9*-nAChR antagonism devoid of any effect on the α7-subtype. Here, single structural changes at the styryl portion of MG624 lead to prevailing α7-nAChR antagonism without abolishing α9*-nAChR antagonism. Nevertheless, rigidification of the styryl into an aromatic bicycle, better if including a H-bond donor NH, such as 5-indolyl ( 31 ), resulted in higher and more selective α7-nAChR affinity. Hybridization of this modification with the constraint of the 2-triethylammoniumethyloxy portion into ( R )- N,N -dimethyl-3-pyrrolidiniumoxy substructure, previously reported as the best modification for the α7-nAChR affinity of MG624 ( 2 ), was a winning strategy. The resulting hybrid 33 had a subnanomolar α7-nAChR affinity and was a potent and selective α7-nAChR antagonist, producing at the α7-, but not at the α9*-nAChR, a profound loss of subsequent ACh function.
Keyphrases
  • ionic liquid
  • capillary electrophoresis
  • intellectual disability
  • anti inflammatory
  • room temperature
  • binding protein